These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4125893)

  • 1. Von Willebrand's disease type B: a newly defined bleeding diathesis.
    Firkin B; Firkin F; Stott L
    Aust N Z J Med; 1973 Jun; 3(3):225-9. PubMed ID: 4125893
    [No Abstract]   [Full Text] [Related]  

  • 2. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of von Willebrand's disease. A comparative study of diagnostic tests on nine families with von Willebrand's disease and its differential diagnosis from hemophilia and thrombocytopathy.
    Lian EC; Deykin D
    Am J Med; 1976 Mar; 60(3):344-56. PubMed ID: 1083143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 1973 look at hemophilia and von Willebrand's disease.
    Ratnoff OD
    Proc Inst Med Chic; 1973; 29(9):296-304. PubMed ID: 4581203
    [No Abstract]   [Full Text] [Related]  

  • 6. Assay of von Willebrand factor in von Willebrand's disease and hemophilia: use of a macroscopic platelet aggregation test.
    Brinkhous KM; Graham JE; Cooper HA; Allain JP; Wagner RH
    Thromb Res; 1975 Mar; 6(3):267-72. PubMed ID: 1078735
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationship between ristocetin-induced platelet aggregation and factor VIII (activity and antigen) in v. Willebrand's disease.
    Barbui T; Battista R; Dini E
    Blut; 1974 Oct; 29(4):260-4. PubMed ID: 4547631
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelet responses to ristocetin in von Willebrand's disease.
    Sanderson JH; Burn AM; Cooke S
    Scand J Haematol; 1974; 12(4):249-55. PubMed ID: 4545782
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter: Willebrand-factor activity and antigen in von Willebrand's disease.
    Meyer D; Jenkins CS; Dreyfus M; Larieu MJ
    Lancet; 1974 Mar; 1(7856):512-3. PubMed ID: 4131919
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter: Bleeding in von Willebrand's disease.
    Ratnoff OD; Saito H
    N Engl J Med; 1974 May; 290(19):1089. PubMed ID: 4545000
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter: Varieties of von Willebrand's disease.
    Peake IR; Bloom AL; Giddings JC
    Lancet; 1974 Jul; 2(7874):222-3. PubMed ID: 4135642
    [No Abstract]   [Full Text] [Related]  

  • 12. Von Willebrand factor: dissociation from antihemophilic factor procoagulant activity.
    Weiss HJ; Hoyer IW
    Science; 1973 Dec; 182(4117):1149-51. PubMed ID: 4127287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological characterization of purified anti-haemophilic factor A (factor VIII) which corrects abnormal platelet retention in Von Willebrand's disease.
    Bouma BN; Wiegerinck Y; Sixma JJ; Van Mourik JA; Mochtar IA
    Nat New Biol; 1972 Mar; 236(65):104-6. PubMed ID: 4112547
    [No Abstract]   [Full Text] [Related]  

  • 14. [Willebrand's disease and platelet adhesiveness in the presence of ristocetine].
    Alexander P; Streiff F; Stoltz JF; Andre E
    Blut; 1975 Aug; 31(2):87-94. PubMed ID: 1080678
    [No Abstract]   [Full Text] [Related]  

  • 15. Recent advances in haemophilia and von Willebrand's disease.
    Ekert H; Firkin BG
    Vox Sang; 1975; 28(6):409-21. PubMed ID: 125001
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter: Clotting factors in von Willebrand's disease.
    Ruggeri ZM; Pareti FI; Bintadish P; Mannucci PM
    Lancet; 1974 Jul; 2(7872):105-6. PubMed ID: 4136883
    [No Abstract]   [Full Text] [Related]  

  • 17. Dissociation between factor VIII (activity and antigen) and ristocetin-induced platelet aggregation in von Willebrand's disease.
    Barbui T; Dini E
    Acta Haematol; 1975; 53(1):44-8. PubMed ID: 807074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor 8 detection by hemagglutination inhibition: hemophilia A and von Willebrand's disease.
    Stites DP; Hershgold EJ; Perlman JD; Fudenberg HH
    Science; 1971 Jan; 171(3967):196-7. PubMed ID: 5312959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of aspirin on platelet aggregation and bleeding time in haemophilia and von Willebrand's disease.
    Praga C; Cortellaro M
    Acta Med Scand Suppl; 1971; 525():219-21. PubMed ID: 5317107
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter: Enhanced factor VIII activity in von Willebrand's disease.
    Mannucci PM; Pareti FI; Ruggeri ZM
    N Engl J Med; 1974 May; 290(22):1259. PubMed ID: 4545219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.